Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 May;86(10):3787–3791. doi: 10.1073/pnas.86.10.3787

Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.

M Wettendorff 1, D Iliopoulos 1, M Tempero 1, D Kay 1, E DeFreitas 1, H Koprowski 1, D Herlyn 1
PMCID: PMC287225  PMID: 2786203

Abstract

We have previously shown that gastrointestinal cancer patients treated with monoclonal antibody CO17-1A (Ab1) developed anti-idiotypic antibodies (Ab2) to the Ab1. We now demonstrate that patients produce anti-anti-idiotypic antibodies (Ab3) to their autologous Ab2. Ab3 were demonstrated in culture supernatants of peripheral blood mononuclear cells from five Ab1-treated patients after stimulation of the cells with heterologous Ab2 that functionally mimicked the tumor antigen (Ag) defined by Ab1 and immunologically cross reacted with the patients' Ab2. Ab3 shared idiotopes with Ab1 and were Ab1-like in their binding specificities to tumor cells, Ag, and Ab2. Such antibodies were also elicited by stimulating cells with Ag. However, they were not produced by stimulating posttreatment mononuclear cells with control proteins or by stimulating pretreatment cells with either Ag or Ab2. Our results demonstrate idiotypic cascades in cancer patients treated with monoclonal antibody. Ag-specific Ab3 responses may underlie delayed clinical responses often observed in cancer patients treated with monoclonal antibodies of various specificities.

Full text

PDF
3790

Images in this article

3788Image
on p.3788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdou N. I., Wall H., Lindsley H. B., Halsey J. F., Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest. 1981 May;67(5):1297–1304. doi: 10.1172/JCI110158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Courtenay-Luck N. S., Epenetos A. A., Sivolapenko G. B., Larche M., Barkans J. R., Ritter M. A. Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies. Lancet. 1988 Oct 15;2(8616):894–897. doi: 10.1016/s0140-6736(88)92482-8. [DOI] [PubMed] [Google Scholar]
  3. DeFreitas E. C., Vella S., Linnenbach A., Zmijewski C., Koprowski H., Croce C. M. Antigen-specific human T-cell hybridomas with helper activity. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6646–6650. doi: 10.1073/pnas.79.21.6646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DeFreitas E., Suzuki H., Herlyn D., Lubeck M., Sears H., Herlyn M., Koprowski H. Human antibody induction to the idiotypic and anti-idiotypic determinants of a monoclonal antibody against a gastrointestinal carcinoma antigen. Curr Top Microbiol Immunol. 1985;119:75–89. doi: 10.1007/978-3-642-70675-2_6. [DOI] [PubMed] [Google Scholar]
  5. Geha R. S. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol. 1982 Jul;129(1):139–144. [PubMed] [Google Scholar]
  6. Geltner D., Franklin E. C., Frangione B. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol. 1980 Oct;125(4):1530–1535. [PubMed] [Google Scholar]
  7. González-Cabrero J., Egido J., Sancho J., Moldenhauer F. Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy. Clin Exp Immunol. 1987 Jun;68(3):694–702. [PMC free article] [PubMed] [Google Scholar]
  8. Herlyn D., Lubeck M., Sears H., Koprowski H. Specific detection of anti-idiotypic immune responses in cancer patients treated with murine monoclonal antibody. J Immunol Methods. 1985 Dec 17;85(1):27–38. doi: 10.1016/0022-1759(85)90271-6. [DOI] [PubMed] [Google Scholar]
  9. Herlyn D., Ross A. H., Iliopoulos D., Koprowski H. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A. Eur J Immunol. 1987 Nov;17(11):1649–1652. doi: 10.1002/eji.1830171120. [DOI] [PubMed] [Google Scholar]
  10. Herlyn D., Sears H., Iliopoulos D., Lubeck M., Douillard J. Y., Sindelar W., Tempero M., Mellstedt H., Maher M., Koprowski H. Anti-idiotypic antibodies to monoclonal antibody CO17-1A. Hybridoma. 1986 Jul;5 (Suppl 1):S51–S58. [PubMed] [Google Scholar]
  11. Herlyn D., Wettendorff M., Schmoll E., Iliopoulos D., Schedel I., Dreikhausen U., Raab R., Ross A. H., Jaksche H., Scriba M. Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8055–8059. doi: 10.1073/pnas.84.22.8055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Herlyn M., Steplewski Z., Herlyn D., Clark W. H., Jr, Ross A. H., Blaszczyk M., Pak K. Y., Koprowski H. Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest. 1983;1(3):215–224. doi: 10.3109/07357908309041361. [DOI] [PubMed] [Google Scholar]
  13. Herlyn M., Steplewski Z., Herlyn D., Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438–1442. doi: 10.1073/pnas.76.3.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Houghton A. N., Mintzer D., Cordon-Cardo C., Welt S., Fliegel B., Vadhan S., Carswell E., Melamed M. R., Oettgen H. F., Old L. J. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1242–1246. doi: 10.1073/pnas.82.4.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  16. Koprowski H., Herlyn D., Lubeck M., DeFreitas E., Sears H. F. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci U S A. 1984 Jan;81(1):216–219. doi: 10.1073/pnas.81.1.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lefvert A. K. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis. Monogr Allergy. 1987;22:57–70. [PubMed] [Google Scholar]
  18. Masouredis S. P., Branks M. J., Victoria E. J. Antiidiotypic IgG crossreactive with Rh alloantibodies in red cell autoimmunity. Blood. 1987 Sep;70(3):710–715. [PubMed] [Google Scholar]
  19. Mazauric T., Mitchell K. F., Letchworth G. J., 3rd, Koprowski H., Steplewski Z. Monoclonal antibody-defined human lung cell surface protein antigens. Cancer Res. 1982 Jan;42(1):150–154. [PubMed] [Google Scholar]
  20. Ross A. H., Herlyn D., Iliopoulos D., Koprowski H. Isolation and characterization of a carcinoma-associated antigen. Biochem Biophys Res Commun. 1986 Feb 26;135(1):297–303. doi: 10.1016/0006-291x(86)90976-9. [DOI] [PubMed] [Google Scholar]
  21. Saxon A., Barnett E. Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid. J Clin Invest. 1984 Feb;73(2):342–348. doi: 10.1172/JCI111218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shoelson S. E., Marshall S., Horikoshi H., Kolterman O. G., Rubenstein A. H., Olefsky J. M. Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes. J Clin Endocrinol Metab. 1986 Jul;63(1):56–61. doi: 10.1210/jcem-63-1-56. [DOI] [PubMed] [Google Scholar]
  23. Tempero M. A., Pour P. M., Uchida E., Herlyn D., Steplewski Z. Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer. Hybridoma. 1986 Jul;5 (Suppl 1):S133–S138. [PubMed] [Google Scholar]
  24. Wettendorff M., Iliopoulos D., Schmoll E., Koprowski H., Herlyn D. Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype. J Immunol Methods. 1989 Jan 6;116(1):105–115. doi: 10.1016/0022-1759(89)90318-9. [DOI] [PubMed] [Google Scholar]
  25. de Saint Basile G., Durandy A., Somme G., Griscelli C. Idiotypy of human anti-Candida albicans antibodies: recurrence, presence of a cross-reactive autoanti-idiotypic-like activity, and role in the induction of specific in vitro antibody response. J Immunol. 1987 Jan 15;138(2):417–422. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES